Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Weiss

Showing results (1581-1590 of 3,056) with videos related to

Pageof 306
Sort By:
The Journal of Clinical Investigation|December 1, 1994
Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndromeH Kojima, D Newton-Nash, H J Weiss, et al.
Oncology|January 1, 1975
A phase III study in lung carcinoma comparing hexamethyl-melamine (NSC 13875) to dibromodulcitol (NSC 104800) 1,2W L Wilson, J V Ryzin, A J Weiss, et al.
Acta Orthopaedica|July 13, 2017
Comparison of metal ion concentrations and implant survival after total hip arthroplasty with metal-on-metal versus metal-on-polyethylene articulationsHenrik Dahlstrand, André Stark, Marius C Wick, et al.
European Journal of Pediatrics|December 29, 2011
Urinary matrix metalloproteinases-2/9 in healthy infants and haemangioma patients prior to and during propranolol therapyC J Kleber, A Spiess, J B Kleber, et al.
Plos One|February 10, 2012
STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinomaBrendan D Looyenga, Danielle Hutchings, Irene Cherni, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1989
Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactamN A Kuck, N V Jacobus, P J Petersen, et al.
Journal of Colloid and Interface Science|May 12, 2023
Uranium surface processes with sandstone and volcanic rocks in acidic and alkaline solutionsJanice P L Kenney, Juan Lezama-Pacheco, Scott Fendorf, et al.
Frontiers in Pharmacology|May 6, 2021
Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung DiseasesSara Rolandsson Enes, Anna D Krasnodembskaya, Karen English, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 9, 2023
Unusual Adverse Events in a Patient With BRAF-Mutated Non-Small Cell Lung Cancer Treated With BRAF/MEK InhibitionRohan Maniar, Stephanie M Gallitano, Sameera Husain, et al.
Cureus|February 6, 2025
Cardiac Kaposi Sarcoma Complicated by Kaposi Sarcoma Inflammatory Cytokine Syndrome: A Case ReportAnna-Maria B Dagher, Jeffrey Lee, Hayley E Cunningham, et al.
Pageof 306

Showing results (1581-1590 of 3,056) with videos related to

Sort By:
Pageof 306
The Journal of Clinical Investigation|December 1, 1994
Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndromeH Kojima, D Newton-Nash, H J Weiss, et al.
Oncology|January 1, 1975
A phase III study in lung carcinoma comparing hexamethyl-melamine (NSC 13875) to dibromodulcitol (NSC 104800) 1,2W L Wilson, J V Ryzin, A J Weiss, et al.
Acta Orthopaedica|July 13, 2017
Comparison of metal ion concentrations and implant survival after total hip arthroplasty with metal-on-metal versus metal-on-polyethylene articulationsHenrik Dahlstrand, André Stark, Marius C Wick, et al.
European Journal of Pediatrics|December 29, 2011
Urinary matrix metalloproteinases-2/9 in healthy infants and haemangioma patients prior to and during propranolol therapyC J Kleber, A Spiess, J B Kleber, et al.
Plos One|February 10, 2012
STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinomaBrendan D Looyenga, Danielle Hutchings, Irene Cherni, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1989
Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactamN A Kuck, N V Jacobus, P J Petersen, et al.
Journal of Colloid and Interface Science|May 12, 2023
Uranium surface processes with sandstone and volcanic rocks in acidic and alkaline solutionsJanice P L Kenney, Juan Lezama-Pacheco, Scott Fendorf, et al.
Frontiers in Pharmacology|May 6, 2021
Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung DiseasesSara Rolandsson Enes, Anna D Krasnodembskaya, Karen English, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 9, 2023
Unusual Adverse Events in a Patient With BRAF-Mutated Non-Small Cell Lung Cancer Treated With BRAF/MEK InhibitionRohan Maniar, Stephanie M Gallitano, Sameera Husain, et al.
Cureus|February 6, 2025
Cardiac Kaposi Sarcoma Complicated by Kaposi Sarcoma Inflammatory Cytokine Syndrome: A Case ReportAnna-Maria B Dagher, Jeffrey Lee, Hayley E Cunningham, et al.
Pageof 306